LOOKING FORWARD TO POTENTIAL BENEFITS
As you begin your Rituxan® (rituximab) treatment, you may be wondering when you may see results and how long they might last. In studies, people who were treated with Rituxan also received methotrexate and glucocorticoids, a type of steroid. At the time of their first checkup—8 weeks after their first infusion—many of those people had seen an improvement in their symptoms. And up to 6 months later, many were still experiencing improvement. Individual results may vary. See below to read more about the results of that trial.
UP TO 6 MONTHS OF SYMPTOM IMPROVEMENT
Rituxan has been shown to provide up to 6 months of symptom improvement from rheumatoid arthritis (RA) in 1 course of treatment (2 infusions, given 2 weeks apart). In fact, a study showed that at 6 months, 51% of the people taking Rituxan (plus methotrexate) experienced RA symptom improvement (called an ACR20 response), as opposed to 18% of people taking methotrexate alone.
A study also showed that, of the people who saw improvement from their first course of Rituxan (plus methotrexate) and then went on to receive a second course, 54% saw an additional 6 months of improvement (as opposed to 45% of people who received methotrexate alone).
SERIOUS SIDE EFFECT INFORMATION
Rituxan can cause serious side effects that can lead to death, including:
- Hepatitis B Virus (HBV) Reactivation: Before you receive your Rituxan treatment, your healthcare provider will do blood tests to check for HBV infection. If you have had hepatitis B or are a carrier of hepatitis B virus, receiving Rituxan could cause the virus to become an active infection again. Hepatitis B reactivation may cause serious liver problems, including liver failure and death. Your healthcare provider will monitor you for hepatitis B infection during and for several months after you stop receiving Rituxan. Tell your healthcare provider right away if you get worsening tiredness, or yellowing of your skin or white part of your eyes during treatment with Rituxan.
For more information, please visit the Important Side Effect Information page.